Latest News
-
Daily Relative Strength Index (RSI) In A Bullish Mode of This Pharma Stock; Buy For TP Rs 635-685 -
HDFC Bank Q4 Preview: Net Profit Likely To Grow 56% YoY; Credila Stake Sale To Fuel Earnings -
1:10 Split, Rs 299/Sh Dividend: Tata's Steel Stock Up 11% In 30-Days, Better Than Nifty; PL Says Accumulate -
625% Dividend, 1:10 Split, 3 Bonus; FMCG ITC Makes Big Acquisition Announcement; Stock Target Prices In April -
2:1 Bonus Issue: IT Penny Stock Turned; 1,600 Shares Market Lot Size Revised To 4,800 Shares -
FREE, FREE, FREE! 3:1 Bonus: Pharma Stock Hits Back-To-Back Upper Circuits; 500 Shares To Earn Rs 1,69,500 -
1:10 Stock Split: Below Rs 10, Fertilizer Sector Turned Ex-Split; 8,282% Returns In 5 Years -
Rs 17/Share Dividend: Record Date On April 26; Buy The ICICI Group Stock To Be Eligible? -
Honasa Consumer to Strengthen Operations by Merging Fusion Cosmeceutics and Just4Kids -
Wipro Reports 7.8% Decline in Q4 Net Profit; CEO Highlights Economic Challenges
3 Best Rated Largecap SIPs To Invest In September, According To Value Research, Invest?
SIPs are one of the best investment opportunities for investors who have a better risk appetite but do not want to invest in stocks directly. Here 3 SIPs have been discussed, best rated (5 star) by Value Research.
Baroda BNP Paribas Large Cap Fund - Direct Plan - Growth
Baroda BNP Paribas Large Cap Fund is a large cap mutual fund SIP investment that has a NAV of Rs. 157.16, and its fund size is Rs. 1325.54 crore. Additionally, the Expense Ratio (ER) of this fund is 0.96%.
In the last 1 year SIP return (absolute return) stood at 2.84%, in the last 2 years it has fetched 15.36% returns, in the last 3 years it has given 31.14% returns, in the last 5 years, it has fetched 48.76% returns. Annualized return from its SIP was 5.28% in the past 1 year, 14.38% in the past 2 years, and 18.4% in the past 3 years.
Canara Robeco Bluechip Equity Fund - Direct Plan - Growth
Canara Robeco Bluechip Equity Fund is a large cap mutual fund SIP investment that has a NAV of Rs. 45.91, and its fund size is Rs. 7593.28 crore. Additionally, the Expense Ratio (ER) of this fund is 0.39%.
In the last 1 year SIP return (absolute return) stood at 1.81%, in the last 2 years it has fetched 14.46% returns, in the last 3 years it has given 32.96% returns, in the last 5 years, it has fetched 54.68% returns. Annualized return from its SIP was 3.36% in the past 1 year, 13.56% in the past 2 years, and 19.38% in the past 3 years.
Axis Bluechip Fund - Direct Plan - Growth
Axis Bluechip Fund is a large cap mutual fund SIP investment that has a NAV of Rs. 49.7, and its fund size is Rs. 35915.36 crore. Additionally, the Expense Ratio (ER) of this fund is 0.52%.
In the last 1 year SIP return (absolute return) stood at 0.04%, in the last 2 years it has fetched 10.92% returns, in the last 3 years it has given 25.5% returns, in the last 5 years, it has fetched 45.7% returns. Annualized return from its SIP was 0.07% in the past 1 year, 10.3% in the past 2 years, and 15.3% in the past 3 years.
SIPs Comparison
The flexi-cap, small-cap, and mid-cap mutual fund SIPs are known for better returns even in the short term, however, the large-cap mutual fund SIPs are popular for their better liquidity and assurance. The three above-mentioned large cap SIPs have been rated 5 star by rating agency Value Research.
In the short term (1 year - 2 years), the Baroda BNP Paribas Large Cap Fund has given the best returns among all three funds, but, in the long term (3 years - 5 years), the Canara Robeco Bluechip Equity Fund has given the best returns. However, if you are concerned about liquidity, you must note that the Axis Bluechip Fund has the highest fund size among the above-mentioned three funds, and its Expense Ratio is also quite lower than the category average.
Disclaimer
Investing in equities/mutual funds/SIPs/ELSS/debts poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, and the author are not liable for any losses caused as a result of decisions based on the article.
(Data till September 2, 2022)
